US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.030
  • +0.030+3.04%
Close Apr 30 16:00 ET
  • 1.000
  • -0.030-2.95%
Post 20:01 ET
119.40MMarket Cap4.12P/E (TTM)

About Coherus BioSciences Company

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Company Profile

SymbolCHRS
Company NameCoherus BioSciences
Listing DateNov 6, 2014
Issue Price13.50
Founded2010
CEOMr. Dennis M. Lanfear
MarketNASDAQ
Employees228
Fiscal Year Ends12-31
Address333 Twin Dolphin Drive,Suite 600
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-649-3530
Websitehttp://www.coherus.com

Company Executives

  • Name
  • Position
  • Salary
  • Dennis M. Lanfear
  • President, Chief Executive Officer and Chairman of the Board
  • 4.80M
  • Bryan J. McMichael
  • Chief Financial Officer and Principal Accounting Officer
  • 1.03M
  • Rita A. Karachun
  • Director
  • 243.12K
  • Georgia L. Erbez
  • Director
  • 287.39K
  • Dr. Michael Ryan, Pharm.D.
  • Director
  • 199.53K
  • Mark D. Stolper
  • Independent Director
  • 200.78K
  • Mats L. Wahlstrom
  • Lead Independent Director
  • 252.03K
  • Charles W. Newton
  • Independent Director
  • 208.91K
  • Ali J. Satvat
  • Independent Director
  • 79.38K
  • Dr. Lee N. Newcomer, M.D.
  • Independent Director
  • 190.16K
  • Dr. Jill O’Donnell-Tormey
  • Independent Director
  • 185.78K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
eBay
EBAY
68.160
Halozyme Therapeutics
HALO
61.420
Constellation Brands
STZ
187.540
4
Workday
WDAY
245.000
5
Lantheus
LNTH
104.340
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.